Recent advances in vaccine and immunotherapy for COVID-19
- PMID: 33156739
- PMCID: PMC7651183
- DOI: 10.1080/21645515.2020.1825896
Recent advances in vaccine and immunotherapy for COVID-19
Abstract
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.
Keywords: COVID-19; SARS-CoV-2; immunotherapeutics; pandemic; vaccine.
References
-
- Leibowitz J. Coronaviruses: molecular and cellular biology. Emerg Infect Dis. 2008;14(4):693b–694. doi:10.3201/eid1404.080016. - DOI
-
- Accessed 2020 August 28. https://www.worldometers.info/world-population/
-
- Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. Features, evaluation and treatment coronavirus (COVID-19). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous